Image

A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (Hope Study, CA-0011)

Join a study on sensory therapy for Alzheimer's symptoms.

Recruiting
50-90 years
All
Phase N/A

This study tests if sensory stimulation (using light and sound) can slow down Alzheimer's disease (AD) progression. Alzheimer's is a brain disorder affecting memory and thinking. The study involves 530 people with mild to moderate AD. Half will use an Active Sensory Stimulation System, and the other half will use a Sham (fake) system. Each group uses their system daily for 12 months. Safety and effectiveness are checked every 3 months with tests like the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) and Mini-Mental State Exam (MMSE). Some participants will also have a lumbar puncture to collect cerebrospinal fluid (CSF) for additional tests.

  • Participation lasts 12 months, including several clinic visits and phone check-ins.
  • Some participants will undergo additional testing like CSF collection.
  • There is no mention of compensation for participation.

To join, you must be 50-90 years old, have mild to moderate AD, and meet specific health criteria. You cannot participate if you have certain medical conditions, drug histories, or have been involved in similar studies. For more details, visit: https://www.hopestudyforad.com/

Study details
    Alzheimer Disease
    Alzheimer Disease 1
    Alzheimer Disease 2
    Alzheimer Disease 3
    Alzheimer Disease
    Early Onset
    Alzheimer Disease
    Late Onset
    Alzheimer Disease 9
    Alzheimer Disease 4
    Alzheimer Disease 7
    Alzheimer Disease 17
    Alzheimer's Dementia Late Onset
    Alzheimer Disease 5
    Alzheimer Disease 6
    Alzheimer Disease 8
    Alzheimer Disease 10
    Alzheimer Disease 11
    Alzheimer Disease 12
    Alzheimer Disease 13
    Alzheimer Disease 14
    Alzheimer Disease 15
    Alzheimer Disease 16
    Alzheimer Disease 18
    Alzheimer Disease 19
    Dementia
    Dementia Alzheimers
    Dementia
    Mild
    Dementia of Alzheimer Type
    Dementia Moderate
    Dementia Senile
    Mild Cognitive Impairment
    Mild Dementia
    MCI
    Cognitive Impairment
    Cognitive Decline
    Cognitive Impairment
    Mild

NCT05637801

Cognito Therapeutics, Inc.

22 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.